SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-027600
Filing Date
2022-10-04
Accepted
2022-10-04 17:28:39
Documents
14
Period of Report
2022-10-02
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37137
2 ex99-1.htm EX-99.1 15698
3 ex99-1_001.jpg GRAPHIC 8729
  Complete submission text file 0001493152-22-027600.txt   241492

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncs-20221002.xsd EX-101.SCH 3224
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncs-20221002_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncs-20221002_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3511
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Filer) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-54318 | Film No.: 221293233
SIC: 2834 Pharmaceutical Preparations